These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 1327398

  • 1. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.
    Heinrichs SC, Pich EM, Miczek KA, Britton KT, Koob GF.
    Brain Res; 1992 May 29; 581(2):190-7. PubMed ID: 1327398
    [Abstract] [Full Text] [Related]

  • 2. Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity.
    Heinrichs SC, Menzaghi F, Pich EM, Baldwin HA, Rassnick S, Britton KT, Koob GF.
    Neuropsychopharmacology; 1994 Nov 29; 11(3):179-86. PubMed ID: 7865099
    [Abstract] [Full Text] [Related]

  • 3. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats.
    Korte SM, Korte-Bouws GA, Bohus B, Koob GF.
    Physiol Behav; 1994 Jul 29; 56(1):115-20. PubMed ID: 8084889
    [Abstract] [Full Text] [Related]

  • 4. Blockade of pituitary-adrenal axis activation induced by peripheral immunoneutralization of corticotropin-releasing factor does not affect the behavioral response to social defeat stress in rats.
    Pich EM, Heinrichs SC, Rivier C, Miczek KA, Fisher DA, Koob GF.
    Psychoneuroendocrinology; 1993 Jul 29; 18(7):495-507. PubMed ID: 8265737
    [Abstract] [Full Text] [Related]

  • 5. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.
    Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW.
    J Neurosci; 1994 May 29; 14(5 Pt 1):2579-84. PubMed ID: 8182429
    [Abstract] [Full Text] [Related]

  • 6. Behavioral effects of central administration of the novel CRF antagonist astressin in rats.
    Spina MG, Basso AM, Zorrilla EP, Heyser CJ, Rivier J, Vale W, Merlo-Pich E, Koob GF.
    Neuropsychopharmacology; 2000 Mar 29; 22(3):230-9. PubMed ID: 10693150
    [Abstract] [Full Text] [Related]

  • 7. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
    Menzaghi F, Howard RL, Heinrichs SC, Vale W, Rivier J, Koob GF.
    J Pharmacol Exp Ther; 1994 May 29; 269(2):564-72. PubMed ID: 8182523
    [Abstract] [Full Text] [Related]

  • 8. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.
    Rassnick S, Heinrichs SC, Britton KT, Koob GF.
    Brain Res; 1993 Mar 05; 605(1):25-32. PubMed ID: 8467387
    [Abstract] [Full Text] [Related]

  • 9. Differential antagonist activity of alpha-helical corticotropin-releasing factor9-41 in three bioassay systems.
    Fisher L, Rivier C, Rivier J, Brown M.
    Endocrinology; 1991 Sep 05; 129(3):1312-6. PubMed ID: 1651845
    [Abstract] [Full Text] [Related]

  • 10. Thyrotropin-releasing factor-induced adrenocorticotropin secretion is mediated by corticotropin-releasing factor.
    Brown MR, Carver-Moore K, Gray TS, Rivier C.
    Endocrinology; 1989 Nov 05; 125(5):2558-62. PubMed ID: 2551657
    [Abstract] [Full Text] [Related]

  • 11. Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze.
    Britton KT, Akwa Y, Spina MG, Koob GF.
    Peptides; 2000 Jan 05; 21(1):37-44. PubMed ID: 10704717
    [Abstract] [Full Text] [Related]

  • 12. Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor.
    Dunn AJ, Antoon M, Chapman Y.
    Brain Res Bull; 1991 Apr 05; 26(4):539-42. PubMed ID: 1868353
    [Abstract] [Full Text] [Related]

  • 13. Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury.
    Lyons MK, Anderson RE, Meyer FB.
    Brain Res; 1991 Apr 05; 545(1-2):339-42. PubMed ID: 1860056
    [Abstract] [Full Text] [Related]

  • 14. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.
    Martínez V, Rivier J, Wang L, Taché Y.
    J Pharmacol Exp Ther; 1997 Feb 05; 280(2):754-60. PubMed ID: 9023288
    [Abstract] [Full Text] [Related]

  • 15. Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.
    Kask A, Rägo L, Harro J.
    Neuroreport; 1997 Nov 10; 8(16):3645-7. PubMed ID: 9427342
    [Abstract] [Full Text] [Related]

  • 16. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.
    Britton KT, Lee G, Vale W, Rivier J, Koob GF.
    Brain Res; 1986 Mar 26; 369(1-2):303-6. PubMed ID: 3008937
    [Abstract] [Full Text] [Related]

  • 17. Stimulant and anxiogenic effects of corticotropin releasing factor.
    Koob GF, Thatcher-Britton K.
    Prog Clin Biol Res; 1985 Mar 26; 192():499-506. PubMed ID: 3878524
    [Abstract] [Full Text] [Related]

  • 18. Alpha-helical CRF blocks differential influence of corticotropin releasing factor (CRF) on appetitive and aversive memory retrieval in rats.
    Kumar KB, Karanth KS.
    J Neural Transm (Vienna); 1996 Mar 26; 103(8-9):1117-26. PubMed ID: 9013399
    [Abstract] [Full Text] [Related]

  • 19. Anxiogenic effect of corticotropin-releasing hormone in the dorsal periaqueductal grey.
    Martins AP, Marras RA, Guimarães FS.
    Neuroreport; 1997 Nov 10; 8(16):3601-4. PubMed ID: 9427334
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility of Lewis and Fischer rats to stress-induced worsening of TNB-colitis: protective role of brain CRF.
    Million M, Taché Y, Anton P.
    Am J Physiol; 1999 Apr 10; 276(4):G1027-36. PubMed ID: 10198347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.